Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

Clinical trial NCT00816959 · UNKNOWN

Trial details

NCT number: NCT00816959
Sponsor: American Scitech International
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Hodgkin's Lymphoma

Start date: 2011-07-01
Primary completion: 2014-04-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.